Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Abbott; Ancora Heart; Medtronic</li><li>Expert testimony - AstraZenca</li><li>Adisory committee - Edwards Lifesciences</li><li>Share Holder - Rocket Pharmaceuticals</li><li>Chief Science Officer - Lexeo Therapeutics</li><li>Advisory Committee - Corstasis Therapeutics</li><li>Founder/Board of Directors - Papillion Therapeutics</li><li>Scientific Advisory Board - Sarnoff Foundation</li></ul>